CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)	Total	Series A Preferred Stock	Series B Preferred Stock	Series D Preferred Stock	Series E Preferred Stock	Common Stock	Total Stockholders’ Equity	Total Stockholders’ Equity Series A Preferred Stock	Total Stockholders’ Equity Series B Preferred Stock	Total Stockholders’ Equity Series D Preferred Stock	Total Stockholders’ Equity Series E Preferred Stock	Total Stockholders’ Equity Common Stock	Preferred Stock Series A Preferred Stock	Preferred Stock Series B Preferred Stock	Preferred Stock Series D Preferred Stock	Preferred Stock Series E Preferred Stock	Common Stock	Common Stock Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Common Stock	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Accumulated Deficit Series A Preferred Stock	Accumulated Deficit Series B Preferred Stock	Accumulated Deficit Series D Preferred Stock	Accumulated Deficit Series E Preferred Stock	Accumulated Deficit Common Stock	Non-controlling interest
Beginning balance (in shares) at Dec. 31, 2022													6,799,467	4,695,887				104,141,899
Beginning balance at Dec. 31, 2022	$ 1,453,919,000						$ 1,439,021,000						$ 68,000	$ 47,000				$ 2,371,000	$ 2,683,169,000		$ 1,147,000	$ (1,247,781,000)						$ 14,898,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Settlement costs to be paid with Common Stock (Note 10)	6,252,000						6,252,000												6,252,000
Common Stock issuance costs						$ (25,000)						$ (25,000)								$ (25,000)
Dividends declared, common stock						(83,351,000)						(83,351,000)										(83,351,000)
Dividends declared, preferred stock		$ (6,162,000)	$ (4,036,000)					$ (6,162,000)	$ (4,036,000)														$ (6,162,000)	$ (4,036,000)
Equity-based compensation, net of forfeitures (in shares)																	293,514
Equity-based compensation, net of forfeitures	5,795,000						1,303,000										$ 3,000		1,300,000									4,492,000
Common stock shares withheld upon vesting of restricted stock	(321,000)						(321,000)										$ (29,057)		(321,000)
Distributions to non-controlling interest holders	(200,000)						(200,000)															(200,000)
Net loss	(27,148,000)						(27,148,000)															(27,148,000)
Cumulative translation adjustment	17,332,000						17,332,000														17,332,000
Designated derivatives, fair value adjustments	(6,886,000)						(6,886,000)														(6,886,000)
Ending balance (in shares) at Jun. 30, 2023													6,799,467	4,695,887				104,406,356
Ending balance at Jun. 30, 2023	1,355,169,000						1,335,779,000						$ 68,000	$ 47,000				$ 2,374,000	2,690,375,000		11,593,000	(1,368,678,000)						19,390,000
Beginning balance (in shares) at Mar. 31, 2023													6,799,467	4,695,887				104,157,910
Beginning balance at Mar. 31, 2023	1,411,612,000						1,394,468,000						$ 68,000	$ 47,000				$ 2,371,000	2,683,827,000		3,702,000	(1,295,547,000)						17,144,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Settlement costs to be paid with Common Stock (Note 10)	6,252,000						6,252,000												6,252,000
Common Stock issuance costs						(4,000)						(4,000)								$ (4,000)
Dividends declared, common stock						$ (41,674,000)						$ (41,674,000)															$ (41,674,000)
Dividends declared, preferred stock		(3,081,000)	(2,018,000)					(3,081,000)	(2,018,000)														(3,081,000)	(2,018,000)
Redemption of OP Units	0
Equity-based compensation, net of forfeitures (in shares)																	277,503
Equity-based compensation, net of forfeitures	2,870,000						624,000										$ 3,000		621,000									2,246,000
Common stock shares withheld upon vesting of restricted stock (in shares)																	(29,057)
Common stock shares withheld upon vesting of restricted stock	(321,000)						(321,000)												(321,000)
Distributions to non-controlling interest holders	(100,000)						(100,000)															(100,000)
Net loss	(26,258,000)						(26,258,000)															(26,258,000)
Cumulative translation adjustment	10,812,000						10,812,000														10,812,000
Designated derivatives, fair value adjustments	(2,921,000)						(2,921,000)														(2,921,000)
Ending balance (in shares) at Jun. 30, 2023													6,799,467	4,695,887				104,406,356
Ending balance at Jun. 30, 2023	1,355,169,000						1,335,779,000						$ 68,000	$ 47,000				$ 2,374,000	2,690,375,000		11,593,000	(1,368,678,000)						19,390,000
Beginning balance (in shares) at Dec. 31, 2023													6,799,467	4,695,887	7,933,711	4,595,175		230,885,197
Beginning balance at Dec. 31, 2023	2,639,149,000						2,637,752,000						$ 68,000	$ 47,000	$ 79,000	$ 46,000		$ 3,639,000	4,350,112,000		(14,096,000)	(1,702,143,000)						1,397,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared, common stock	(145,677,000)						(145,677,000)															(145,677,000)
Dividends declared, preferred stock		(6,162,000)	(4,036,000)	$ (7,438,000)	$ (4,236,000)			(6,162,000)	(4,036,000)	$ (7,438,000)	$ (4,236,000)												(6,162,000)	(4,036,000)	$ (7,438,000)	$ (4,236,000)
Equity-based compensation, net of forfeitures (in shares)																	(16,475)
Equity-based compensation, net of forfeitures	4,313,000						3,406,000												3,406,000									907,000
Common stock shares withheld upon vesting of restricted stock (in shares)																	(63,347)
Common stock shares withheld upon vesting of restricted stock	(424,000)						(424,000)										$ (1,000)		(423,000)
Distributions to non-controlling interest holders	(73,000)																											(73,000)
Net loss	(59,415,000)						(59,415,000)															(59,415,000)
Cumulative translation adjustment	1,498,000						1,498,000														1,498,000
Designated derivatives, fair value adjustments	5,765,000						5,765,000														5,765,000
Ending balance (in shares) at Jun. 30, 2024													6,799,467	4,695,887	7,933,711	4,595,175		230,805,375
Ending balance at Jun. 30, 2024	2,423,264,000						2,421,033,000						$ 68,000	$ 47,000	$ 79,000	$ 46,000		$ 3,638,000	4,353,095,000		(6,833,000)	(1,929,107,000)						2,231,000
Beginning balance (in shares) at Mar. 31, 2024													6,799,467	4,695,887	7,933,711	4,595,175		230,846,571
Beginning balance at Mar. 31, 2024	2,526,668,000						2,524,859,000						$ 68,000	$ 47,000	$ 79,000	$ 46,000		$ 3,639,000	4,351,577,000		(11,844,000)	(1,818,753,000)						1,809,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared, common stock	(63,754,000)						(63,754,000)															(63,754,000)
Dividends declared, preferred stock		$ (3,081,000)	$ (2,018,000)	$ (3,719,000)	$ (2,118,000)			$ (3,081,000)	$ (2,018,000)	$ (3,719,000)	$ (2,118,000)												$ (3,081,000)	$ (2,018,000)	$ (3,719,000)	$ (2,118,000)
Equity-based compensation, net of forfeitures (in shares)																	17,203
Equity-based compensation, net of forfeitures	2,340,000						1,886,000												1,886,000									454,000
Common stock shares withheld upon vesting of restricted stock (in shares)																	(58,399)
Common stock shares withheld upon vesting of restricted stock	(369,000)						(369,000)										$ (1,000)		(368,000)
Distributions to non-controlling interest holders	(32,000)																											(32,000)
Net loss	(35,664,000)						(35,664,000)															(35,664,000)
Cumulative translation adjustment	2,472,000						2,472,000														2,472,000
Designated derivatives, fair value adjustments	2,539,000						2,539,000														2,539,000
Ending balance (in shares) at Jun. 30, 2024													6,799,467	4,695,887	7,933,711	4,595,175		230,805,375
Ending balance at Jun. 30, 2024	$ 2,423,264,000						$ 2,421,033,000						$ 68,000	$ 47,000	$ 79,000	$ 46,000		$ 3,638,000	$ 4,353,095,000		$ (6,833,000)	$ (1,929,107,000)						$ 2,231,000